These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20308435)

  • 21. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.
    Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB
    Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased oxidative DNA damage in mammary tumor cells by continuous epidermal growth factor stimulation.
    Hamada J; Nakata D; Nakae D; Kobayashi Y; Akai H; Konishi Y; Okada F; Shibata T; Hosokawa M; Moriuchi T
    J Natl Cancer Inst; 2001 Feb; 93(3):214-9. PubMed ID: 11158190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
    Budach V
    Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
    [No Abstract]   [Full Text] [Related]  

  • 24. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma.
    Söderdahl G; Bäckman L; Isoniemi H; Cahlin C; Höckerstedt K; Broomé U; Mäkisalo H; Friman S; Ericzon BG
    Transpl Int; 2006 Apr; 19(4):288-94. PubMed ID: 16573544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated liver perfusion for liver metastases: pharmacokinetic advantage?
    Ravikumar TS; Dixon K
    Surg Oncol Clin N Am; 1996 Apr; 5(2):443-9. PubMed ID: 9019363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of pegylated liposomal doxorubicin in ovarian cancer.
    Thigpen JT; Aghajanian CA; Alberts DS; Campos SM; Gordon AN; Markman M; McMeekin DS; Monk BJ; Rose PG
    Gynecol Oncol; 2005 Jan; 96(1):10-8. PubMed ID: 15589573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hand-foot syndrome related to liposomal doxorubicin.
    Swenson KK; Bell EM
    Oncol Nurs Forum; 2010 Mar; 37(2):137-9. PubMed ID: 20189920
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
    Scherübl H; Schaaf L; Raue F; Faiss S; Zeitz M
    Dtsch Med Wochenschr; 2004 Mar; 129(13):689-92. PubMed ID: 15026965
    [No Abstract]   [Full Text] [Related]  

  • 29. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.
    Weinberg BD; Patel RB; Exner AA; Saidel GM; Gao J
    J Control Release; 2007 Dec; 124(1-2):11-9. PubMed ID: 17900740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated liposomal doxorubicin: a guide to its use in various malignancies.
    Lyseng-Williamson KA; Duggan ST; Keating GM
    BioDrugs; 2013 Oct; 27(5):533-40. PubMed ID: 24018470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy.
    Kaminskas LM; McLeod VM; Ryan GM; Kelly BD; Haynes JM; Williamson M; Thienthong N; Owen DJ; Porter CJ
    J Control Release; 2014 Jun; 183():18-26. PubMed ID: 24637466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination.
    Granda TG; Filipski E; D'Attino RM; Vrignaud P; Anjo A; Bissery MC; Lévi F
    Cancer Res; 2001 Mar; 61(5):1996-2001. PubMed ID: 11280758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes].
    Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model.
    Chen JH; Ling R; Yao Q; Li Y; Chen T; Wang Z; Li KZ
    Endocr Relat Cancer; 2005 Mar; 12(1):93-100. PubMed ID: 15788641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radiofrequency ablation: basic principles, techniques and challenges].
    Pereira PL; Trübenbach J; Schmidt D
    Rofo; 2003 Jan; 175(1):20-7. PubMed ID: 12525976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 38. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.
    Schmidinger M; Wenzel C; Locker GJ; Muehlbacher F; Steininger R; Gnant M; Crevenna R; Budinsky AC
    Br J Cancer; 2001 Dec; 85(12):1850-2. PubMed ID: 11747325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
    Fennelly D; Kelsen DP
    Hepatogastroenterology; 1996; 43(8):356-62. PubMed ID: 8714228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer.
    O'Brien ME
    Anticancer Drugs; 2008 Jan; 19(1):1-7. PubMed ID: 18043124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.